Cynosure develops, manufactures and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women’s health. The Company also markets radiofrequency (RF) energy-sourced medical devices for precision surgical applications such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. Cynosure’s product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, Q-switched lasers, intense pulsed light and RF technology. Cynosure sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names through a direct sales force in the United States, Canada, France, Morocco, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 120 other countries.

Webcast ImageWebcast
Q3 2016 Cynosure Inc. Earnings Conference Call (Replay)
10/25/16 at 9:00 a.m. ET
Q3 2016 Cynosure Inc. Earnings Conference Call
Tuesday, October 25, 2016 9:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
CYNO (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 0.63 (1.50%)
Data as of 10/27/16 12:15 p.m. ET
Minimum 20 minute delay
Refresh quote

News Releases

October 25, 2016
Cynosure Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent from Prior Year to $106.4 Million
October 11, 2016
Cynosure To Host Third-Quarter 2016 Financial Results Conference Call On October 25
September 30, 2016
Cynosure Recognized as One of FORTUNE's 100 Fastest-Growing Companies
View All Press Releases

Upcoming Events

There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed.